US2055063A - Suppository medication - Google Patents

Suppository medication Download PDF

Info

Publication number
US2055063A
US2055063A US51542A US5154235A US2055063A US 2055063 A US2055063 A US 2055063A US 51542 A US51542 A US 51542A US 5154235 A US5154235 A US 5154235A US 2055063 A US2055063 A US 2055063A
Authority
US
United States
Prior art keywords
suppository
base
stearic
ester
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US51542A
Inventor
John C Bird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Hoffmann La Roche Inc
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to US51542A priority Critical patent/US2055063A/en
Application granted granted Critical
Publication of US2055063A publication Critical patent/US2055063A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Definitions

  • My invention relates to a medicament and especially to a medicament intended for suppository use. More particularly, my invention lies in the discovery of a new base for suppository med-- ication.
  • Suppositories are used for various types of medical treatment, including local treatment, as in hemorrhoidal and other rectal conditions, vaginitis, cervicitis, leucorrhea, and the like; treatment of constipation, as, for example, by glycerin or soap suppositories; and absorption, either for purposes of narcosis, alimentation or for ultimate effect upon more remote organs.
  • oil which tends to leak out of the body oil which tends to leak out of the body. Furthermore, the oily nature protects any water soluble constituents which may be included in the suppository from solution in the aqueous body fluids, and holds 011 soluble medicaments in firm solution so that they are not readily available to the part to be treated. Also, the addition of many common medicaments, particularly insoluble solids such as bismuth or zinc compounds, raises the melting point of cocoa butter so that the suppository does not readily melt in the body and the medicament is not released but is held in agglomerated lumps of the cocoa butter and is thus excreted. Inextreme cases such suppositories may be excreted whole.
  • a new type of suppository vehicle has been discovered which is free of the disadvantages described above and which possesses many features which render suppository medication more efficacious and reliable.
  • the primary object of the invention then is to provide a suppository base which is not ofan oily or fatty nature, and which may therefore carry medicaments in such a condition that they are readily available to the body.
  • a further object is to provide a material of Inc., a corporation of Application November 25, 1935," Serial No. 51,542
  • this type which is capable of absorbing a comparatively large quantity of water and of automatically forming an emulsion with the water, thereby swelling to abulk several times greater than its original volume.
  • Still another object is to provide a suppository base which may be used in spite of the addi-" tion of medicamentswhich may raise the melting point thereof.
  • a further purpose is to provide such a base which is of neutral reaction so that no irritation can occur.
  • stearic esters of glycerin or glycols as a base.
  • the preferred material is the stearic ester of propylene glycol. This material as commercially obtained melts in the neighborhood of 37 C. or close to the body temperature.
  • glycerin mono-stearate, ethylene glycol stearate, diethylene glycol stearate and other stearic esters of glycerin or glycols particularly such as are rendered self-emulsifying in warm water, when used with a small proportion of an emulsifying agent-
  • the esters of other .fatty acids such as palmitic; myristic, lauric, or
  • the base also includes an emulsifying agent.
  • agent should preferably be one which is not an irritant and does not have an unpleasant odor, and is moreover, without action on the medicament, and I have found that triethanolamine stearate is most satisfactory for this purpose.
  • agents such as sodium or potassium stearate, stearates of ethylamine and diethylamine, monoethanolamine and diethanolamine stearates, as well as the palmitates and oleates corresponding to the stearates mentioned, might 'be used.
  • I utilize as a preliminary basis about 95% propylene glycol ester and about 5% triethanolamine stearate.
  • this proportion is not critical and the emulsifying agent may be used in 45 amounts of from 1 to 10% or even in greater quantities.
  • stearic acid may be added in an amount from 5 to 20% of the base material. 50
  • a base composed of 82% propylene glycol stearate, 2%-3% triethanolamine, and about 15% stearic acid forms an eminently satisfactory suppository material. It consists normally of a white, or ivory colored, waxy solid, which softens or melts at body temperature.
  • the .material possesses the property of absorbing comparatively large quantities of water as referred to its own size and of forming an emulsion automatically with warm aqueous fluids so that it swells to a bulk several times its original volume.
  • glycerin or other glycol stearates which have higher melting points around 45 0., and above, it may be necessary to add materials which will lower the melting point of the base, such as cocoanut'oil, petrolatum, mineraloil, and the like.
  • materials which will lower the melting point of the base such as cocoanut'oil, petrolatum, mineraloil, and the like.
  • suiiicient emulsifying agent is alsoincluded to overcome this difliculty. This in turn should not be great enough to render the reaction too alkaline and irritant.
  • Such a material is further eminently satisfactory for introducing medicaments into the various body passages. medicaments, these will be dispersed in finely divided condition through the emulsion which is formed and will thus be brought'into effective contact with the various parts to be treated.
  • Water soluble medicaments will be immediately dissolved, liberated and extracted through the absorption 'of water owing to the hydrophilic property of the base, and are thus rendered available to the tissues. Any oils or fats which may have been incorporated are emulsified and thus held in a condition for effective action, and
  • insoluble medicaments are normally to raise the melting point of materials such as I have described. However, as the actual melting of the base is not absolutely necessary,
  • astringents such compounds as zinc oxide, compounds of bismuth (as the resorcinate, gallate, subcarbonate, iodide or iodotannate), boric acid, ephedrine,-ichthyol, tannic acid and the like may be included.
  • a particular formula for such use might be as follows:
  • a plastic medicinal object comprising av fatty acid ester of a substance selected from the group consisting of glycerin and glycols.
  • a suppository comprising an ester of a fatty' acid selected from the group consisting of stearic, palmitic, myristic and lauric acids and of a substance selected from the group consisting of glycerin and glycols.
  • a suppository comprising a fatty. acid ester of propylene glycol.
  • a plastic medicinal object comprising the stearic ester of propylene glycol.
  • a suppository comprising a stearic ester of a substance selected from the group consisting ofglycerin and glycols together with an emulsifying agent.
  • a suppository comprising the stearic ester of propylene glycol together with an emulsifying agent comprising a substance selected from the group, consisting of stearates, palmitates and oleates of amines, diamines and triamines.
  • a suppository comprising the stearic ester of propylene glycol and triethanolamine stearate.
  • a suppository comprising from 90 to 99% stearic ester of propylene glycol and from 1 to 10% of triethanolamine stearate.
  • a suppository comprising a base material consisting essentially of from 90 to 99% stearic ester of propylene glycol and from 1.to 10% triethanolamine stearate, and stearic acid in an amount from 5 to 20% of the base.
  • a suppository comprising a base of a stearic ester of a substance selected from the group consisting of glycerin and glycols, an emulsifying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Description

Patented Sept. 22, 1936 PATENT OFFICE SUPPOSITORY DEDICATION John 0. Bird, Upper Montclair, N. 1., assignor to Hoii'mann-La Roche New Jersey No Drawing.
10 Claims.
My invention relates to a medicament and especially to a medicament intended for suppository use. More particularly, my invention lies in the discovery of a new base for suppository med-- ication.
Suppositories are used for various types of medical treatment, including local treatment, as in hemorrhoidal and other rectal conditions, vaginitis, cervicitis, leucorrhea, and the like; treatment of constipation, as, for example, by glycerin or soap suppositories; and absorption, either for purposes of narcosis, alimentation or for ultimate effect upon more remote organs.
, oil which tends to leak out of the body. Furthermore, the oily nature protects any water soluble constituents which may be included in the suppository from solution in the aqueous body fluids, and holds 011 soluble medicaments in firm solution so that they are not readily available to the part to be treated. Also, the addition of many common medicaments, particularly insoluble solids such as bismuth or zinc compounds, raises the melting point of cocoa butter so that the suppository does not readily melt in the body and the medicament is not released but is held in agglomerated lumps of the cocoa butter and is thus excreted. Inextreme cases such suppositories may be excreted whole.
On the other hand, some attempts have been made to use ointments for rectal and vaginal medication, but these require special packages and applicatory devices.
According to the present invention, a new type of suppository vehicle has been discovered which is free of the disadvantages described above and which possesses many features which render suppository medication more efficacious and reliable. The primary object of the invention then is to provide a suppository base which is not ofan oily or fatty nature, and which may therefore carry medicaments in such a condition that they are readily available to the body. 1
A further object is to provide a material of Inc., a corporation of Application November 25, 1935," Serial No. 51,542
this type which is capable of absorbing a comparatively large quantity of water and of automatically forming an emulsion with the water, thereby swelling to abulk several times greater than its original volume.
Still another object is to provide a suppository base which may be used in spite of the addi-" tion of medicamentswhich may raise the melting point thereof.
A further purpose is to provide such a base which is of neutral reaction so that no irritation can occur.
I have discovered that the above advantages may be obtained by the use of stearic esters of glycerin or glycols as a base. The preferred material is the stearic ester of propylene glycol. This material as commercially obtained melts in the neighborhood of 37 C. or close to the body temperature. However, it is, also possible to use glycerin mono-stearate, ethylene glycol stearate, diethylene glycol stearate and other stearic esters of glycerin or glycols, particularly such as are rendered self-emulsifying in warm water, when used with a small proportion of an emulsifying agent- Furthermore, the esters of other .fatty acids, such as palmitic; myristic, lauric, or
the like, might be employed.
According to the preferred embodiment of my invention, the base also includes an emulsifying agent. Such agent should preferably be one which is not an irritant and does not have an unpleasant odor, and is moreover, without action on the medicament, and I have found that triethanolamine stearate is most satisfactory for this purpose. However, other agents such as sodium or potassium stearate, stearates of ethylamine and diethylamine, monoethanolamine and diethanolamine stearates, as well as the palmitates and oleates corresponding to the stearates mentioned, might 'be used.
According to the preferred form of the invention, I utilize as a preliminary basis about 95% propylene glycol ester and about 5% triethanolamine stearate. However, this proportion is not critical and the emulsifying agent may be used in 45 amounts of from 1 to 10% or even in greater quantities.
In addition, if it is desirable to adjust the pH value of the product, stearic acid may be added in an amount from 5 to 20% of the base material. 50
A base composed of 82% propylene glycol stearate, 2%-3% triethanolamine, and about 15% stearic acid forms an eminently satisfactory suppository material. It consists normally of a white, or ivory colored, waxy solid, which softens or melts at body temperature. The .material possesses the property of absorbing comparatively large quantities of water as referred to its own size and of forming an emulsion automatically with warm aqueous fluids so that it swells to a bulk several times its original volume. When the material is inserted into the body, the movement of the muscles and tissues, whether voluntary or involuntary, will cause a maceration or agitation of the suppository resulting in the formation of a large soft mass in the form of a hydrophilic ointment or cream. Such a mass will more readily fill the anal canal, or spread into the various cavities of the passages into which it is inserted, and will tend to coat the mucosa with a protective layer. Such a material is itself extremely satisfactory for the treatment of constipation, as opposed to other bulk-producing compounds'which are ordinarily introduced by the mouth.
' Where glycerin or other glycol stearates are used, which have higher melting points around 45 0., and above, it may be necessary to add materials which will lower the melting point of the base, such as cocoanut'oil, petrolatum, mineraloil, and the like. However, such substances should not be added in quantities large enough to prevent emulsification unless suiiicient emulsifying agent is alsoincluded to overcome this difliculty. This in turn should not be great enough to render the reaction too alkaline and irritant.
Such a material is further eminently satisfactory for introducing medicaments into the various body passages. medicaments, these will be dispersed in finely divided condition through the emulsion which is formed and will thus be brought'into effective contact with the various parts to be treated.
Water soluble medicaments will be immediately dissolved, liberated and extracted through the absorption 'of water owing to the hydrophilic property of the base, and are thus rendered available to the tissues. Any oils or fats which may have been incorporated are emulsified and thus held in a condition for effective action, and
cannot leak or seep out. Such suppositories are thusavaiiable for use at any time and are not restricted to recumbent cases.
The action of insoluble medicaments is normally to raise the melting point of materials such as I have described. However, as the actual melting of the base is not absolutely necessary,
. (self-emulsification readily taking place) large proportions of such insoluble medicaments may now be used without'detriment and with greater efiiciency.
, Various types of medicaments may be used, and the present invention is -not limited to any particular type. For example, astringents, antiseptics, emollients, healing adjuncts and local In the case of insoluble analgesics may be incorporated. In suppositories to be used for the treatment of hemorrhoidai conditions, such compounds as zinc oxide, compounds of bismuth (as the resorcinate, gallate, subcarbonate, iodide or iodotannate), boric acid, ephedrine,-ichthyol, tannic acid and the like may be included. A particular formula for such use might be as follows:
While I have described herein some embodi ments of my invention, I wish it to be understood that I do not intend to, limit myself thereby except within the scope of the appended claims.
I claim: 1. A plastic medicinal object comprising av fatty acid ester of a substance selected from the group consisting of glycerin and glycols.
2. A suppository comprising an ester of a fatty' acid selected from the group consisting of stearic, palmitic, myristic and lauric acids and of a substance selected from the group consisting of glycerin and glycols.
3. A suppository comprising a fatty. acid ester of propylene glycol.
4. A plastic medicinal object comprising the stearic ester of propylene glycol.
5. A suppository, comprising a stearic ester of a substance selected from the group consisting ofglycerin and glycols together with an emulsifying agent.
6. A suppository comprising the stearic ester of propylene glycol together with an emulsifying agent comprising a substance selected from the group, consisting of stearates, palmitates and oleates of amines, diamines and triamines.
'7. A suppository comprising the stearic ester of propylene glycol and triethanolamine stearate.
8. A suppository comprising from 90 to 99% stearic ester of propylene glycol and from 1 to 10% of triethanolamine stearate.
9. A suppository comprising a base material consisting essentially of from 90 to 99% stearic ester of propylene glycol and from 1.to 10% triethanolamine stearate, and stearic acid in an amount from 5 to 20% of the base.
10. A suppository comprising a base of a stearic ester of a substance selected from the group consisting of glycerin and glycols, an emulsifying
US51542A 1935-11-25 1935-11-25 Suppository medication Expired - Lifetime US2055063A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US51542A US2055063A (en) 1935-11-25 1935-11-25 Suppository medication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51542A US2055063A (en) 1935-11-25 1935-11-25 Suppository medication

Publications (1)

Publication Number Publication Date
US2055063A true US2055063A (en) 1936-09-22

Family

ID=21971945

Family Applications (1)

Application Number Title Priority Date Filing Date
US51542A Expired - Lifetime US2055063A (en) 1935-11-25 1935-11-25 Suppository medication

Country Status (1)

Country Link
US (1) US2055063A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2467884A (en) * 1944-02-02 1949-04-19 Nathaniel M Elias Spermicides
US2469618A (en) * 1945-09-21 1949-05-10 Eaton Lab Inc Vaginal suppository
US2538127A (en) * 1948-02-26 1951-01-16 Searle & Co Medicated suppositories and bases therefor
US2696456A (en) * 1950-04-24 1954-12-07 Lambert Company Dual element suppository
US2713019A (en) * 1951-01-31 1955-07-12 Allied Lab Inc Antibiotic pharmaceutical preparation containing polyethylene glycol diester as vehicle
DE941014C (en) * 1949-05-19 1956-03-29 Edelfettwerke G M B H Process for the production of suppository masses
DE1015576B (en) * 1953-12-12 1957-09-12 Edelfettwerke Ges Mit Beschrae Process for the production of suppository compounds
US2993063A (en) * 1956-12-17 1961-07-18 Colgate Palmolive Co Cocoa butter substitute and process of making same
US3062716A (en) * 1960-02-08 1962-11-06 Applic Chimiques D Etudes Et D Method of treating hemorrhoids
US4879119A (en) * 1984-02-21 1989-11-07 Yamanouchi Pharmaceutical Co., Ltd. Patch
EP1319397A1 (en) * 2000-09-21 2003-06-18 Taisho Pharmaceutical Co., Ltd Suppositories sustained in the lower rectum

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2467884A (en) * 1944-02-02 1949-04-19 Nathaniel M Elias Spermicides
US2469618A (en) * 1945-09-21 1949-05-10 Eaton Lab Inc Vaginal suppository
US2538127A (en) * 1948-02-26 1951-01-16 Searle & Co Medicated suppositories and bases therefor
DE941014C (en) * 1949-05-19 1956-03-29 Edelfettwerke G M B H Process for the production of suppository masses
US2696456A (en) * 1950-04-24 1954-12-07 Lambert Company Dual element suppository
US2713019A (en) * 1951-01-31 1955-07-12 Allied Lab Inc Antibiotic pharmaceutical preparation containing polyethylene glycol diester as vehicle
DE1015576B (en) * 1953-12-12 1957-09-12 Edelfettwerke Ges Mit Beschrae Process for the production of suppository compounds
US2993063A (en) * 1956-12-17 1961-07-18 Colgate Palmolive Co Cocoa butter substitute and process of making same
US3062716A (en) * 1960-02-08 1962-11-06 Applic Chimiques D Etudes Et D Method of treating hemorrhoids
US4879119A (en) * 1984-02-21 1989-11-07 Yamanouchi Pharmaceutical Co., Ltd. Patch
EP1319397A1 (en) * 2000-09-21 2003-06-18 Taisho Pharmaceutical Co., Ltd Suppositories sustained in the lower rectum
US20030185861A1 (en) * 2000-09-21 2003-10-02 Seiichi Hori Suppository of retaining in lower region of rectum
EP1319397A4 (en) * 2000-09-21 2004-02-04 Taisho Pharmaceutical Co Ltd Suppositories sustained in the lower rectum
AU2001288039B2 (en) * 2000-09-21 2005-09-15 Taisho Pharmaceutical Co., Ltd. Suppositories sustained in the lower rectum
US7022335B2 (en) 2000-09-21 2006-04-04 Taisho Pharmaceutical Co., Ltd. Suppository of retaining in lower region of rectum

Similar Documents

Publication Publication Date Title
US2055063A (en) Suppository medication
US4486412A (en) Encapsulated antacid dispersions
US4551148A (en) Vaginal delivery systems and their methods of preparation and use
US3244589A (en) Alkyl phenoxy polyethoxy ether spermicidal aerosol
US2149005A (en) Shaped medicinal preparation
US2241331A (en) Suppository
US2054989A (en) Compositions for application to the human skin
FI85105C (en) suppository
US2550622A (en) Ointment base and iodine ointment
US3259545A (en) Stable aluminum hydroxide gel or aluminum hydroxide-sodium zirconium lactate antiperspirant stick
US2696456A (en) Dual element suppository
EP0099477B1 (en) Use of a sulfonated homo- or copolymer of styrene for the manufacture of a contraceptive composition
EP0848948B1 (en) Long-lasting composition for rectal administration
JP2519029B2 (en) Formulation for vaginal delivery
US4755378A (en) Iodophor-containing suppository
US4410517A (en) Vitamin E (tocopherol) compositions which resemble petrolatum
US2114370A (en) Agent for the treatment of mucous surfaces
US2361756A (en) Ointments and the like
US2469618A (en) Vaginal suppository
US2157831A (en) Stabilized antiseptic cream
US439581A (en) Ointment
DE3230602C2 (en)
US2114369A (en) Topical germicidal medicine
EP2440178A2 (en) Glycerol-free osmotic laxative suppository
US3262849A (en) Suppository base compositions